Encompass Health (EHC) to Release Earnings on Wednesday

Encompass Health (NYSE:EHC) will be posting its quarterly earnings results after the market closes on Wednesday, April 24th. Analysts expect Encompass Health to post earnings of $0.93 per share for the quarter. Encompass Health has set its FY24 guidance at $3.77-$4.06 EPS and its FY 2024 guidance at 3.770-4.060 EPS.Individual that wish to register for the company’s earnings conference call can do so using this link.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Wednesday, February 7th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.83 by $0.12. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. The business had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.24 billion. On average, analysts expect Encompass Health to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Encompass Health Stock Down 0.9 %

EHC stock opened at $79.98 on Wednesday. The stock’s 50 day simple moving average is $77.01 and its 200 day simple moving average is $70.09. Encompass Health has a fifty-two week low of $57.55 and a fifty-two week high of $83.73. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.28 and a current ratio of 1.28. The company has a market cap of $8.01 billion, a P/E ratio of 23.05, a price-to-earnings-growth ratio of 1.49 and a beta of 0.94.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date of this dividend was Thursday, March 28th. Encompass Health’s dividend payout ratio (DPR) is currently 17.29%.

Institutional Investors Weigh In On Encompass Health

Institutional investors have recently made changes to their positions in the stock. Worth Asset Management LLC purchased a new stake in shares of Encompass Health in the first quarter worth $35,000. Quarry LP purchased a new stake in shares of Encompass Health in the first quarter worth $42,000. Belpointe Asset Management LLC raised its position in shares of Encompass Health by 88.2% in the first quarter. Belpointe Asset Management LLC now owns 781 shares of the company’s stock worth $42,000 after buying an additional 366 shares in the last quarter. Benjamin Edwards Inc. raised its position in shares of Encompass Health by 89.0% in the second quarter. Benjamin Edwards Inc. now owns 1,087 shares of the company’s stock worth $74,000 after buying an additional 512 shares in the last quarter. Finally, First Horizon Advisors Inc. raised its position in shares of Encompass Health by 18.8% in the first quarter. First Horizon Advisors Inc. now owns 1,415 shares of the company’s stock worth $77,000 after buying an additional 224 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on the company. Barclays upped their price target on Encompass Health from $95.00 to $101.00 and gave the stock an “overweight” rating in a research note on Thursday, March 28th. Truist Financial increased their price objective on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research note on Friday, February 9th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $83.00 target price on shares of Encompass Health in a report on Friday, February 9th. Mizuho upped their target price on Encompass Health from $77.00 to $82.00 and gave the company a “buy” rating in a report on Friday, February 9th. Finally, Stephens reissued an “overweight” rating and set a $85.00 price objective on shares of Encompass Health in a report on Tuesday, January 16th. Eight analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $83.22.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.